4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000950170-24-010796
Chief Financial Officer sold 15,000 shares at $85.45 ($1,281,750)
- Chief Financial Officer acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gordon Stephen · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,833 | $13.28 | $117,302 | 21,908 | D |
| 2024-02-01 | Exercise or conversion : show line 2 in the form 10b5-1 | +3,644 | $16.14 | $58,814 | 25,552 | D |
| 2024-02-01 | Exercise or conversion : show line 3 in the form 10b5-1 | +2,523 | $38.46 | $97,035 | 28,075 | D |
| 2024-02-01 | Sale : show line 4 in the form 10b5-1 | −15,000 | $85.45 | $1,281,750 | 13,075 | D |
| Open-market sales · 15,000 sh · avg $85.45 · $1,281,750 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-01 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −8,833 | 28,167 | D |
| 2024-02-01 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −3,644 | 2,084 | D |
| 2024-02-01 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −2,523 | 67,477 | D |
Loading xslF345X05/ownership.xml…